Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ananthakrishnan

Showing results (431-440 of 592) with videos related to

Pageof 60
Sort By:
Gastroenterology|July 31, 2012
Hormone therapy increases risk of ulcerative colitis but not Crohn's diseaseHamed Khalili, Leslie M Higuchi, Ashwin N Ananthakrishnan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 5, 2012
Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health StudyAshwin N Ananthakrishnan, Hamed Khalili, An Pan, et al.
Inflammatory Bowel Diseases|November 24, 2023
Differential Impact of Smoking on Methylome and Transcriptome in Crohn's Disease and Ulcerative ColitisQi Yan Ang, Damian Plichta, Sean Kim, et al.
The American Journal of Gastroenterology|May 19, 2026
Microbiome-Directed Therapy for Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Placebo-Controlled Trial of Multi-Strain Probiotic SupplementationNienke Z Borren, Emma Paulides, Marjolein A Y Klaassen, et al.
Alimentary Pharmacology & Therapeutics|December 9, 2021
Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohortsKevin Casey, Emily W Lopes, Blake Niccum, et al.
Journal of Crohn'S & Colitis|November 18, 2017
Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel DiseasesNienke Z Borren, Grace Conway, John J Garber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisNeeraj Narula, Nicole H Chang, Danah Mohammad, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2021
Sugars and Gastrointestinal HealthDjésia Arnone, Caroline Chabot, Anne-Charlotte Heba, et al.
Inflammatory Bowel Diseases|May 23, 2009
Durability of infliximab in Crohn's disease: a single-center experienceJason E Gonzaga, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Digestive Diseases and Sciences|October 10, 2020
Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort StudyNienke Z Borren, Emma Paulides, Jody L Frinack, et al.
Pageof 60

Showing results (431-440 of 592) with videos related to

Sort By:
Pageof 60
Gastroenterology|July 31, 2012
Hormone therapy increases risk of ulcerative colitis but not Crohn's diseaseHamed Khalili, Leslie M Higuchi, Ashwin N Ananthakrishnan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 5, 2012
Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health StudyAshwin N Ananthakrishnan, Hamed Khalili, An Pan, et al.
Inflammatory Bowel Diseases|November 24, 2023
Differential Impact of Smoking on Methylome and Transcriptome in Crohn's Disease and Ulcerative ColitisQi Yan Ang, Damian Plichta, Sean Kim, et al.
The American Journal of Gastroenterology|May 19, 2026
Microbiome-Directed Therapy for Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Placebo-Controlled Trial of Multi-Strain Probiotic SupplementationNienke Z Borren, Emma Paulides, Marjolein A Y Klaassen, et al.
Alimentary Pharmacology & Therapeutics|December 9, 2021
Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohortsKevin Casey, Emily W Lopes, Blake Niccum, et al.
Journal of Crohn'S & Colitis|November 18, 2017
Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel DiseasesNienke Z Borren, Grace Conway, John J Garber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisNeeraj Narula, Nicole H Chang, Danah Mohammad, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2021
Sugars and Gastrointestinal HealthDjésia Arnone, Caroline Chabot, Anne-Charlotte Heba, et al.
Inflammatory Bowel Diseases|May 23, 2009
Durability of infliximab in Crohn's disease: a single-center experienceJason E Gonzaga, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Digestive Diseases and Sciences|October 10, 2020
Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort StudyNienke Z Borren, Emma Paulides, Jody L Frinack, et al.
Pageof 60